Titles
- 3.7 million people would gain health coverage in 2023 if the remaining 12 states were to expand Medicaid eligibility1
- 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff1
- 340B Drug Discount Program: oversight of the Intersection with the Medicaid Drug Rebate Program needs improvement : report to Congressional requesters1
- 510(k) third party review program: guidance for industry, Food and Drug Administration staff, and third party review organizations1
- 7 steps to expand the behavioral health capabilities of your workforce: a guide to help move you forward1
- 90 percent of U.S. adults report increased stress due to coronavirus pandemic1
- A Medicare Buy-in program1
- A balancing act: state long-term care reform1
- A best practices approach to treating maternal hemorrhage: Titus Regional Medical Center : Mount Pleasant, Texas1
- A better way: team care for children with special health care needs1
- A brief overview of our Medicaid data sources1
- A call for federal action to improve nursing facilities1
- A call to lead: the case for accelerating academic health center transformation1
- A check up on U.S. global health policy, after one year of the Trump administraton1
- A close look at Medi-Cal managed care: quality, access, and the provider's experience under geographic managed care1
- A close look at Medi-Cal managed care: statewide quality trends from the last decade1
- A close look at Medi-Cal managed care: stories of quality improvement success1
- A closer look at the remaining uninsured population eligible for Medicaid and CHIP1
- A community health worker model to address childhood asthma: perspectives of program participants1
- A comparison of brand-name drug prices among selected federal programs1